Chromadex Corp Stock
Price
Target price
€3.42
€3.42
-1.120%
-0.04
-1.120%
€5.58
09.05.24 / Tradegate
WKN: A2AG5N / Symbol: CDXC / Name: ChromaDex / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Chromadex Corp Stock
We can see a decrease in the price for Chromadex Corp. Compared to yesterday it has lost -€0.040 (-1.120%).
With 10 Buy predictions and only 2 Sell predictions the community sentiment for the stock is positive.
As a result the target price of 5 € shows a positive potential of 46.2% compared to the current price of 3.42 € for Chromadex Corp.
For the coming years our community has positive and negative things to say abot the Chromadex Corp stock. Criterium "EBIT Margin" gathered the most positive votes but regarding "EBIT Margin" there were negative voices in the community.
Pros and Cons of Chromadex Corp in the next few years
Pros
?
B****
?
S********** s********
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Chromadex Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Chromadex Corp | -1.120% | 10.559% | -8.247% | 187.097% | 165.672% | -42.581% | - |
| Organovo Holdings Inc. | -6.110% | -11.423% | -7.338% | -49.773% | -13.840% | -85.626% | -95.105% |
| Intellia Therapeutics Inc | 4.950% | 6.833% | -8.148% | -45.455% | -26.010% | -61.558% | 44.779% |
| VBI Vaccines Inc. | 0.540% | 5.962% | -14.706% | -77.871% | 3.962% | -99.164% | -98.942% |
Comments
ChromaDex Co. (NASDAQ: CDXC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
Show more
Ratings data for CDXC provided by MarketBeat
ChromaDex Co. (NASDAQ: CDXC) had its price target raised by analysts at Roth Mkm from $4.25 to $6.00. They now have a "buy" rating on the stock.
Show more
Ratings data for CDXC provided by MarketBeat
ChromaDex Co. (NASDAQ: CDXC) is now covered by analysts at StockNews.com. They set a "strong-buy" rating on the stock.
Show more
Ratings data for CDXC provided by MarketBeat